Nature Search

Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores

Paula Saffie-Awad
Spencer M. Grant
Sara Bandres-Ciga
ResearchOpen Access03 Jul 2025
npj Parkinson's Disease

Volume: 11, P: 1-13
Fine-mapping and candidate gene investigation within the PARK10 locus

Kristoffer Haugarvoll
Mathias Toft
Matthew J Farrer
Research15 Oct 2008
European Journal of Human Genetics

Volume: 17, P: 336-343
Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

Multi-ancestry genome-wide association analyses identify new risk loci for Parkinson’s disease, and fine-mapping and co-localization analyses implicate candidate genes whose expression is associated with disease susceptibility.

Jonggeol Jeffrey Kim
Dan Vitale
Ignacio Mata
ResearchOpen Access28 Dec 2023
Nature Genetics

Volume: 56, P: 27-36
Genome-wide determinants of mortality and motor progression in Parkinson’s disease

Manuela M. X. Tan
Michael A. Lawton
Huw R. Morris
ResearchOpen Access07 Jun 2024
npj Parkinson's Disease

Volume: 10, P: 1-15
Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)

Lara M. Lange
Micol Avenali
Masharip Atadzhanov
Amendments and CorrectionsOpen Access13 Sept 2023
npj Parkinson's Disease

Volume: 9, P: 1-3
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids

Rosa Rademakers and colleagues show that mutations in CSF1R cause hereditary diffuse leukoencephalopathy with spheroids, a central nervous system white-matter disease with variable clinical presentations that include personality and behavioral changes, dementia, depression, parkinsonism and seizures.

Rosa Rademakers
Matt Baker
Zbigniew K Wszolek
Research25 Dec 2011
Nature Genetics

Volume: 44, P: 200-205
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Julie Williams, Michael Owen and colleagues report staged follow-up and meta-analyses of genome-wide association studies for Alzheimer's disease from the GERAD+ consortium. They identify common variants at ABCA7 and MS4A6A/MS4A4E associated with Alzheimer's disease and support for several additional susceptibility loci.

Paul Hollingworth
Denise Harold
Julie Williams
Research03 Apr 2011
Nature Genetics

Volume: 43, P: 429-435
The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population

Lara M. Lange
Kristin Levine
Masharip Atadzhanov
ResearchOpen Access25 Mar 2025
npj Parkinson's Disease

Volume: 11, P: 1-10
Genotype–phenotype correlation in PRKN-associated Parkinson’s disease

Poornima Jayadev Menon
Sara Sambin
Jean Christophe Corvol
ResearchOpen Access29 Mar 2024
npj Parkinson's Disease

Volume: 10, P: 1-12
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)

Clodagh Towns
Madeleine Richer
Masharip Atadzhanov
ResearchOpen Access12 Sept 2023
npj Parkinson's Disease

Volume: 9, P: 1-6
Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants

Roy N. Alcalay
Jan Aasly
Karen Marder
Correspondence05 Aug 2014
Genetics in Medicine

Volume: 16, P: 644-645

Search

Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores

Fine-mapping and candidate gene investigation within the PARK10 locus

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

Genome-wide determinants of mortality and motor progression in Parkinson’s disease

Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)

Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population

Genotype–phenotype correlation in PRKN-associated Parkinson’s disease

Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants

Search

Quick links

Search

Filter By:

Search

Quick links